home · filing · 0001683168-26-003446
8-K filed May 4, 2026, 7:59 PM ET
ticker VBIO
CIK 0001787740
leadership
confidence high
sentiment neutral
materiality 0.50
Valion Bio appoints Melinda Lackey as General Counsel and SVP of Legal Affairs
Valion Bio, Inc.
Melinda Lackey, age 49, appointed as GC and SVP of Legal Affairs, effective May 4, 2026.
Prior role: SVP Legal & Administration at Alaunos Therapeutics (TCRT); also served at Kuur Therapeutics and Winston & Strawn.
Employment agreement: base salary $321,000/year, eligible for annual bonus up to 35% of base, and option grant of 45,000 shares.
Lackey will oversee legal functions for Valion's Entolimod ARS program and CDMO subsidiary Velocity Bioworks.
Company (Nasdaq: VBIO) is a clinical-stage immunotherapeutics firm advancing Entolimod via FDA Animal Rule pathway.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2026-05-04
Filed May 4, 2026, 7:59 PM ET
On May 4, 2026, Melinda Lackey was appointed as General Counsel and Senior Vice President of Legal Affairs of Valion Bio, Inc.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Melinda Lackey was appointed as General Counsel and Senior Vice President of Legal Affairs at Valion Bio, Inc..
Action appointed
Role General Counsel and Senior Vice President of Legal Affairs
Exact text from the filing
On May 4, 2026, Melinda Lackey was appointed as General Counsel and Senior Vice President of Legal Affairs of Valion Bio, Inc.
View on SEC.gov
Source: SEC EDGAR
accession 0001683168-26-003446
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.